Biggest News Aggregation in the World
📰 Trial Notification News

Trial Notification News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Trial Notification. Real-time updates on events, politics, business and more.

Invex Therapeutics approved to start Presendin phase three clinical trial in Australia

Clinical-stage biopharmaceutical company Invex Therapeutics (ASX: IXC) has been given the green light to start its EVOLVE phase three clinical trial in Australia on patients with idiopathic intracranial hypertension (IIH).
United Kingdom Alex Sinclair Australia Human Research Ethics Committee Human Research Ethics Committee Therapeutics Goods Administration Australia Therapeutics Goods Administration

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science